Refine your search

Content type
Tags
Jurisdiction
Language

425 results found

Global Competition Review logo
Launched in 1997, GCR is an essential daily resource for over 10,000 competition professionals worldwide and is recognised as the world's leading…
Event

Global Competition Review | 28 Mar 2023

GCR Awards 2023

Event

Global Competition Review | United Kingdom | 9 Mar 2023

GCR Live: Telecoms, Media & Technology

Event

Global Competition Review | USA | 2 Feb 2023

GCR Live: Law Leaders Global 2023

Event

Global Competition Review | United Kingdom | 6 Dec 2022

GCR Live: Foreign Investment Control 2022

Event

Global Competition Review | Canada, USA | 1 Dec 2022

GCR Live: Antitrust in Pharmaceuticals

Article
Ask Lexy

Global Competition Review | European Union, United Kingdom | 21 Oct 2022

United Kingdom: a Key Jurisdiction for Competition Law Compliance

In the United Kingdom, the Competition and Markets Authority (CMA) has had a clear competition law enforcement focus on the life sciences sector in…
Article
Ask Lexy

Global Competition Review | European Union, France | 21 Oct 2022

Product Denigration

Denigration cases in the life sciences area have been rare in the EU as well as worldwide, and in most cases the denigration behaviour is combined…
Article
Ask Lexy

Global Competition Review | Australia | 21 Oct 2022

Australia: ACCC’s Focus on Conduct Could Have Far-Reaching Implications

The Australian Competition and Consumer Commission (ACCC) is a highly trusted regulator in Australia and its role continues to expand. Unlike digital…
Article
Ask Lexy

Global Competition Review | Italy | 21 Oct 2022

Italy: Antitrust Pioneer Continues to Break Ground on Theories of Harm

Italy has always been a pioneer in the enforcement of antitrust law in the pharmaceutical sector, with landmark cases such as the Aspen case on…
Article
Ask Lexy

Global Competition Review | European Union, France | 21 Oct 2022

France: FCA Increases Scrutiny Over the Sector

France is a key jurisdiction to consider when discussing the life sciences sector. This chapter presents the main recent antitrust developments in…
Previous page 1 2 3 ...